Previous Close | 71.61 |
Open | 71.61 |
Bid | 82.50 |
Ask | 86.30 |
Strike | 170.00 |
Expire Date | 2024-05-17 |
Day's Range | 71.61 - 71.61 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
RESEARCH TRIANGLE PARK, N.C., May 02, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024.
IQVIA Holdings' (IQV) first-quarter 2024 revenues are likely to have benefited from growth in the Technology and Analytics, and Research and Development segments.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for IQVIA (IQV), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.